This is a preprint.
Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity
- PMID: 33594379
- PMCID: PMC7885938
- DOI: 10.1101/2020.10.14.20212803
Characteristics and Factors Associated with COVID-19 Infection, Hospitalization, and Mortality Across Race and Ethnicity
Update in
-
Characteristics and Factors Associated With Coronavirus Disease 2019 Infection, Hospitalization, and Mortality Across Race and Ethnicity.Clin Infect Dis. 2021 Dec 16;73(12):2193-2204. doi: 10.1093/cid/ciab154. Clin Infect Dis. 2021. PMID: 33608710 Free PMC article.
Abstract
Background: Data on the characteristics of COVID-19 patients disaggregated by race/ethnicity remain limited. We evaluated the sociodemographic and clinical characteristics of patients across racial/ethnic groups and assessed their associations with COVID-19 outcomes.
Methods: This retrospective cohort study examined 629,953 patients tested for SARS-CoV-2 in a large health system spanning California, Oregon, and Washington between March 1 and December 31, 2020. Sociodemographic and clinical characteristics were obtained from electronic health records. Odds of SARS-CoV-2 infection, COVID-19 hospitalization, and in-hospital death were assessed with multivariate logistic regression.
Results: 570,298 patients with known race/ethnicity were tested for SARS-CoV-2, of whom 27.8% were non-White minorities. 54,645 individuals tested positive, with minorities representing 50.1%. Hispanics represented 34.3% of infections but only 13.4% of tests. While generally younger than White patients, Hispanics had higher rates of diabetes but fewer other comorbidities. 8,536 patients were hospitalized and 1,246 died, of whom 56.1% and 54.4% were non-White, respectively. Racial/ethnic distributions of outcomes across the health system tracked with state-level statistics. Increased odds of testing positive and hospitalization were associated with all minority races/ethnicities. Hispanic patients also exhibited increased morbidity, and Hispanic race/ethnicity was associated with in-hospital mortality (OR: 1.39 [95% CI: 1.14-1.70]).
Conclusion: Major healthcare disparities were evident, especially among Hispanics who tested positive at a higher rate, required excess hospitalization and mechanical ventilation, and had higher odds of in-hospital mortality despite younger age. Targeted, culturally-responsive interventions and equitable vaccine development and distribution are needed to address the increased risk of poorer COVID-19 outcomes among minority populations.
Keywords: COVID-19; SARS-CoV-2; health disparity; public health; race/ethnicity.
Conflict of interest statement
Conflicts of Interest JRH reports fees and support from PACT Pharma, Isoplexis, Indi Molecular, Nanostring, Merck, Atlasxomics outside the submitted work. JDG performed contracted research with Gilead Sciences, Regeneron Pharmaceuticals and Eli Lilly; JDG also has received grants from Monogram Biosciences and Viracor outside of the submitted work. Dr. Diaz reports other work from Gilead Sciences, Lexicon Pharmaceuticals, Safeology, Inc, Regeneron, Roche, Boehringer Ingelheim, and Edesa Biotech outside the submitted work.
Figures

References
-
- CDC. COVID-19 Hospitalization and Death by Race/Ethnicity. 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-disc.... Accessed 17 August 2020.
-
- Moore JT. Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June 2020. MMWR Morb Mortal Wkly Rep 2020; 69. Available at: https://www.cdc.gov/mmwr/volumes/69/wr/mm6933e1.htm. Accessed 12 October 2020. - PMC - PubMed
-
- Artiga S, Corallo B, Pham O. Racial Disparities in COVID-19: Key Findings from Available Data and Analysis - Issue Brief. KFF. 2020; Available at: https://www.kff.org/report-section/racial-disparities-in-covid-19-key-fi.... Accessed 17 August 2020.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous